Back to results
US 2023/0146591 A1Published application
Binding molecules to cd38 and pd-l1
AssigneeBiomunex Pharmaceuticals
InventorsEUGENE ZHUKOVSKY, OLIVIER LEGER, RICHARD J. MORSE
Life of this patent
Estimating the term…
Abstract
The present invention relates to a bispecific molecule comprising at least one anti-CD38 domain and at least one anti-PD-L1 domain, which are capable of simultaneous binding to CD38 and PD-L1 antigens, respectively.
Claims16
A bispecific molecule comprising at least one anti-CD38 domain and at least one anti-PD-L1 domain, which are capable of simultaneous binding to CD38 and PD-L1 antigens, respectively.
Dependencies are inferred from the claim text.